Comparable stake leader
Mr. Bryan Baldasare
SEC ownership of MERIDIAN BIOSCIENCE INC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000794172.
Disclosed value leader
Mr. Bryan Baldasare
Comparable rows
0/2
Latest evidence
12 Jan 2022
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Mr. Bryan Baldasare
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
12 Jan 2022
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0000794172
- Issuer location
- Cincinnati, OH
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of MERIDIAN BIOSCIENCE INC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Mr. Bryan Baldasare
Disclosed value leader
Mr. Bryan Baldasare
Comparable rows
0/2
Latest evidence
12 Jan 2022
3/4/5
Highest disclosed value: $1,241,733
2 rows are not safely comparable across share classes.
Quick read
Mr. Bryan Baldasare has the largest disclosed position value at $1.24M.
0 of 2 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Mr. Bryan Baldasare's linked filing trail.
Disclosed position value
Top 2
Mr. Bryan Baldasare
$1.24M
David Phillips
$286.2K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-2 of 2 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Mr. Bryan Baldasare |
3/4/5
Exec VP & CFO
|
—
class O/S missing
|
$1,241,733
60,929 shares
|
— | 15 Dec 2021 |
| David Phillips |
3/4/5
Director
|
—
class O/S missing
|
$286,237
14,045 shares
|
— | 12 Jan 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 25 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-14 of 14 reporting-owner rows connected to MERIDIAN BIOSCIENCE INC. Open a relationship link for the CIK-to-CIK filing trail.
Rows
14
Largest Forms 3/4/5 holder
Mr. Bryan Baldasare
Net 12M change
$0
Latest report
31 Jan 2023
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Mr. Bryan Baldasare | Exec VP & CFO | $1,241,733 | Mixed | 15 Dec 2021 | ||
| David Phillips | Director | $286,237 | Mixed | 12 Jan 2022 | ||
| Catherine Sazdanoff | Director | Mixed | 31 Jan 2023 | |||
| Lourdes G. Weltzien | Executive VP, Life Science | Mixed | 31 Jan 2023 | |||
| Julie Diana Smith | Sr VP, Controller, PAO | Mixed | 31 Jan 2023 | |||
| John McCune Rice Jr. | Director | Mixed | 31 Jan 2023 | |||
| Felicia Williams | Director | Mixed | 31 Jan 2023 | |||
| Anthony P. Bihl III | Director | Mixed | 31 Jan 2023 | |||
| John P. Kenny | Chief Executive Officer, Director, 10%+ Owner | Mixed | 31 Jan 2023 | |||
| Tony Serafini-Lamanna | Executive VP-Diagnostics | Mixed | 31 Jan 2023 | |||
| Dwight E. Ellingwood | Director | Mixed | 31 Jan 2023 | |||
| Andrew S. Kitzmiller | Executive Vice President & CFO | Mixed | 31 Jan 2023 | |||
| John McIlwraith | Director | Mixed | 31 Jan 2023 | |||
| James M. Anderson | Director | Mixed | 31 Jan 2023 |
Recent insider transactions for MERIDIAN BIOSCIENCE INC
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.